Basilea Pharmaceutica News
Most Popular Basilea Pharmaceutica Story
Basilea lands $510M co-marketing pact with Astellas
Switzerland's Basilea nailed a $510 million co-marketing pact with Astellas Pharma, hauling in a $70 million upfront payment and gaining a partner who will take over Phase III development of the... Read more...
Latest Headlines
- February 24, 2010
- February 19, 2010
- January 29, 2010
- December 31, 2009
- January 27, 2009
- November 26, 2008
- March 18, 2008
- February 13, 2008
- October 9, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
